Skip to main content
. Author manuscript; available in PMC: 2017 May 31.
Published in final edited form as: N Engl J Med. 2014 Mar 31;370(21):2002–2013. doi: 10.1056/NEJMoa1401329

Table 2.

Medication Use at Baseline and at 3 Years.*

Medication At Baseline At 3 Years
Medical
Therapy
(N = 40)
Gastric
Bypass
(N = 48)
Sleeve
Gastrectomy
(N = 49)
Medical
Therapy
(N = 40)
Gastric
Bypass
(N = 48)
Sleeve
Gastrectomy
(N = 49)
Diabetes medications

  No. of medications 2.80±1.11 2.50±1.15 2.45±1.19 2.60±1.10 0.48±0.80 1.02±1.01

  Insulin — no. of patients (%) 21 (52) 22 (46) 22 (45) 22 (55) 3 (6) 4 (8)

  Not taking this class of medication — no. of patients (%) 1 (2) 1 (2) 1 (2) 1 (2) 33 (69) 21 (43)

Cardiovascular medications

  No. of medications 2.70±1.22 2.73±1.32 2.18±1.09 2.63±1.31 0.96±1.15 1.35±1.40

  ACE inhibitor or ARB — no. of patients (%) 25 (62) 36 (75) 30 (61) 22 (55) 11 (23)§ 13 (27)§

  Not taking this class of medication — no. of patients (%) 0 3 (6) 2 (4) 1 (2) 20 (42) 19 (39)

Any medication

  No. of medications 5.50±1.71 5.23±1.76 4.63±1.67 5.23±1.86 1.44±1.49 2.37±1.82

  Difference from baseline to 3 yr — no. −0.28±2.03 −3.79±1.81 −2.27±1.99
*

Plus–minus values are means ±SD. All P values are for the comparison with the medical-therapy group unless otherwise indicated. ACE denotes angiotensin-converting enzyme, and ARB angiotensin-receptor blocker.

P<0.001.

P<0.05 for comparison between gastric bypass and sleeve gastrectomy.

§

P<0.01.